Our news

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights

Nov 12, 2024

READ MORE

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Nov 7, 2024

READ MORE

Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma

Nov 5, 2024

READ MORE

Legend Biotech Appoints Alan Bash as President of CARVYKTI®

Nov 4, 2024

READ MORE

Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results

Oct 24, 2024

READ MORE

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

Oct 3, 2024

READ MORE

Why we do what we do

We focus on serious and intractable diseases to help patients around the world.

PLAY VIDEO

Learn about us

Explore our technologies

We are technology agnostic in targeting hematologic malignancies and solid tumors. We are exploring 4 different technologies to help treat disease.

READ MORE

Meet our leadership team

Our leaders bring significant expertise from some of the world’s largest pharma companies.

READ MORE

Understand our capabilities

We are an end-to-end cell therapy company. Our capabilities extend from discovery to commercialization.

READ MORE

Work with us

We offer a variety of career choices that support the development of novel therapies.

READ MORE

Our pipeline

Our pipeline is comprised of investigational agents and innovative technologies in personalized medicine. We are devoted to exploring the potential of cell therapies to treat diseases that are considered intractable and incurable, including hematological malignancies and solid tumors.

LEARN MORE
close

You are about to leave LegendBiotech.com

You are going to a website that Legend Biotech does not operate and to which Legend Biotech's privacy policy does not apply. Legend Biotech is not responsible for the content, format, maintenance or policies of the website you are about to visit and does not endorse or monitor any content on such website.

We use cookies to improve your experience on our website, measure performance, understand our audience, for advertising and support purposes. You can always change your preferences or opt out from our use of cookies.